Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells.
Up-regulation of IRF-3 expression through GATA-1 acetylation by histone deacetylase inhibitor in lung adenocarcinoma A549 cells.
复制标题
组蛋白脱乙酰酶抑制剂通过 GATA-1 乙酰化上调肺腺癌 A549 细胞中 IRF-3 的表达
DOI:
10.18632/oncotarget.18371
复制
发表时间:
2017-09-29
期刊:
影响因子:
--
通讯作者:
Zhou GP
中科院分区:
文献类型:
--
作者:
Wang LL;Zhou LB;Shu J;Li NN;Zhang HW;Jin R;Zhuang LL;Zhou GP
Interferon regulatory factor 3 (IRF-3) is an important transcription factor for interferon genes. Although its functional activation by viral infection has been widely explicated, the regulatory mechanism of IRF-3 gene expression in cancer cells is poorly understood. In this study, we demonstrated treatment of lung adenocarcinoma A549 cells with trichostatin A (TSA) and valproic acid (VPA), two different classes of histone deacetylase inhibitors, strongly stimulated IRF-3 gene expression. Truncated and mutated IRF-3 promoter indicated that a specific GATA-1 element was responsible for TSA-induced activation of IRF-3 promoter. Chromatin immunoprecipitation and electrophoretic mobility shift assay showed that TSA treatment increased the binding affinity of GATA-1 to IRF-3 promoter. Using immunoprecipitation assay and immunoblotting, we demonstrated that TSA increased the level of acetylated GATA-1 in A549 cells. In summary, our study implied that TSA enhanced IRF-3 gene expression through increased GATA-1 recruitment to IRF-3 promoter and the acetylation level of GATA-1 in lung adenocarcinoma A549 cells.
登录
查看更多内容
影响因子:
--
作者:
Li Y;Ke Q;Shao Y;Zhu G;Li Y;Geng N;Jin F;Li F
通讯作者:
Li F
影响因子:
14.9
作者:
Bresnick EH;Katsumura KR;Lee HY;Johnson KD;Perkins AS
通讯作者:
Perkins AS
影响因子:
--
作者:
Pradhan S;Mahajan D;Kaur P;Pandey N;Sharma C;Srivastava T
通讯作者:
Srivastava T
影响因子:
4.6
作者:
Homma T;Ishibashi D;Nakagaki T;Fuse T;Sano K;Satoh K;Atarashi R;Nishida N
通讯作者:
Nishida N
影响因子:
16
作者:
Crispino, JD;Lodish, MB;Orkin, SH
通讯作者:
Orkin, SH